Hair Regrowth in a Patient with Alopecia Universalis and Psoriasis Vulgaris Under Deucravacitinib Therapy
February 2025
in “
JDDG Journal der Deutschen Dermatologischen Gesellschaft
”
TLDR Deucravacitinib helped a man regrow hair and improve psoriasis.
A 51-year-old man with alopecia universalis (AU) and psoriasis vulgaris experienced significant hair regrowth after treatment with Deucravacitinib, a TYK2 inhibitor. Despite previous ineffective topical treatments, the patient's hair, including eyebrows and scalp hair, began to regrow within 6 weeks of starting Deucravacitinib, with substantial improvement observed over 7 months. The patient's Psoriasis Area and Severity Index (PASI) improved from 8 to 4, and the Severity of Alopecia Tool Score (SALT-Score) decreased from 97 to 13. The Dermatology Life Quality Index (DLQI) also improved significantly. No adverse events were reported. This case suggests Deucravacitinib may be effective for AU, warranting further controlled studies.